Actionable news
0
All posts from Actionable news
Actionable news in CLCD: CoLucid Pharmaceuticals Inc,

Ladenburg Thalmann Maintains Buy on CoLucid Pharmaceuticals, Raises PT to $52.00, Positive On Outlook For Lasmiditan

RECENT PRO ALERTS

Latest Ratings for CLCD

DateFirmActionFromTo
Sep 2016Ladenburg ThalmannMaintainsBuy
Jun 2015PiperJaffrayInitiates Coverage onOverweight
Jun 2015StifelInitiates Coverage onBuy